A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients.

Clinical trial NCT07040956 · COMPLETED

Trial details

NCT number: NCT07040956
Sponsor: West China Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma Low-dose Radiotherapy Immunotherapy Targeted Therapy

Start date: 2025-06-28
Primary completion: 2026-06-26
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.